mRNA–lipid-nanoparticle vaccines do not require type 1 conventional dendritic (cDC1) cells or the WDFY4-dependent cross-presentation pathway for CD8+ T cell priming but, instead, engage both cDC1 and cDC2 cells redundantly.
<li>den Haan, J. M. M., Lehar, S. M. & Bevan, M. J. CD8+ but not CD8 dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med.192, 16851696 (2000).
Article
Google Scholar
</li><li>…
Artikel ini bersumber dari Nature.com pada April 15, 2026 at 9:51 PM.
To view and participate in discussions about this article, please visit the original source.
View Original Article